Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.

Published in: Stem cell research & therapy (2020)

MSC-Exo may serve as a promising tool in the treatment of SARS-CoV-2 pneumonia. However, further work needs to be carried out to confirm the efficacy of exosomes in the treatment of SARS-CoV-2 pneumonia.

Keyphrases

sars cov
mesenchymal stem cells
respiratory syndrome coronavirus
stem cells
bone marrow
intensive care unit
umbilical cord
coronavirus disease
extracorporeal membrane oxygenation